George Tziras
Vermögen: 452 490 $ am 31.08.2026
Vermögen: 452 490 $ am 31.08.2026
George Tziras is currently Chief Executive Officer & Director at Small Pharma, Inc. since 2022, Non-Executive Director at Cybin UK Ltd. since 2015, and Chief Business Officer at Cybin, Inc. starting in 2025.
Formerly, Mr. Tziras was Chief Business Officer & Director at Unilock Capital Corp.
Education includes undergraduate studies at the University of Oxford and graduate studies at The Paul H.
Nitze School of Advanced International Studies.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CYBIN, INC. 0.06% | 02.09.2026 | 38’477 ( 0.06% ) | 452 490 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SMALL PHARMA INC. | Vorstandsvorsitzender | 20.07.2022 |
| CYBIN INC. | Investor Relations Kontakt | - |
Small Pharma Ltd.
Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops rapid-acting antidepressant | Direktor/Vorstandsmitglied | 01.01.2015 |
| Unternehmen | Position | Ende |
|---|---|---|
| SMALL PHARMA INC. | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Paul H. Nitze School of Advanced International Studies
The Paul H. Nitze School of Advanced International Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Small Pharma Ltd.
Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops rapid-acting antidepressant | Health Technology |
Unilock Capital Corp.
Unilock Capital Corp. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
Cybin, Inc.
Cybin, Inc. Pharmaceuticals: MajorHealth Technology Manufactures neurological pharmaceuticals | Health Technology |
Small Pharma, Inc.
Small Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a neuro pharmaceutical company that develops therapeutic treatments for mental health disorders | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen